Who We Are -
America's Biotech Backbone
MBAA was founded to represent and protect the interests of midsized biopharmaceutical innovators which is an essential segment of America’s life sciences ecosystem.
Fast Facts:
U.S. R&D investment in 2024
$
0
B
R&D over the last decade
$
0
B
High-Skill U.S. Workers
0
Candidates in development
0
Average time to product launch
0
Years
Average time to profitability
0
Years
Our members have evolved from early-stage research partners to fully integrated innovators, proving that America’s biotech model works.
Our Members
MBAA companies contribute directly to America’s economic and health leadership:
Strengthening the Economy:
Over $14 billion in annual U.S. revenue and a growing domestic manufacturing base.
Creating High-Wage Jobs:
Nearly half of all U.S. employees in member companies work in R&D.
Improving Patient Lives:
Over 20 FDA special designations and 30 orphan drug designations for unmet medical needs.
Together, our members form what would be the 21st largest pharmaceutical company in the world by revenue, yet our size makes us especially vulnerable to harmful, one-size-fits-all policies.
Join the Alliance:
Join a growing coalition of biotech leaders who are shaping the future of U.S. innovation.
Membership Offers:
- A unified voice in Washington.
- Access to policy intelligence and industry data.
- Collaboration with peers to promote growth and support innovation.